We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Minimally Invasive Device Market to Experience Growth

By HospiMedica International staff writers
Posted on 02 Sep 2013
The worldwide market for minimally invasive surgery (MIS) devices is poised for expansion. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

MIS, which can be performed on both an inpatient and outpatient basis, appeals to patients because it means less blood loss, smaller surgical scars, shorter hospital stays, and fewer pain medications. Additional incentives involve payer programs that focus on prevention. A typical MIS procedure is performed through small incisions using specialized instruments, miniature cameras and fiber-optic light sources, and high definition (HD) monitors. In most cases, incisions are up to 10 cm in length, instead of the 15–20 cm incision required by traditional surgery.

The most common MIS procedure is small and large intestine endoscopy, which may or may not include biopsy. Gastrointestinal system MIS procedures supersede any other segment, with approximately 12 million surgeries performed in the United States alone; surgery involving the orthopedic system is another growth area for MIS techniques and equipment, with 40%–50% of knee surgeries in the United States and developed regions in Europe performed using MIS. Inguinal herniorrhaphy surgery follows with several million performed annually.

“The minimally invasive surgery devices market is well positioned for growth in the next five years,” said Kalorama analyst and report author Mary Ann Crandall. “Advances in technology, biologics, stem cell research, and regenerative medicine will help to expand opportunities of MIS. A concentration on earlier intervention for the prevention of disease will also stimulate the MIS market.”

According to Kalorama Information, the worldwide market for devices used in MIS procedures has experienced a number of technological advances over the years, providing surgeons with clinical options, which were previously only available as an invasive procedure. The market was valued at USD 27 billion in 2012, representing a 5.4% increase over 2010 figures.

Related Links:

Kalorama Information



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Powered Surgical Stapler
ECHELON 3000 Stapler
New
Portable Digital Floor Scale
DR400C
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.